Angiotensin II Increases Monocyte Binding to Endothelial Cells

Authors: Kim J.A.¹; Berliner J.A.²; Nadler J.L.¹

Source: Biochemical and Biophysical Research Communications, Volume 226, Number 3, September 1996 , pp. 862-868(7)

Buy & download fulltext article:

The full text article is not available for purchase.

The publisher only permits individual articles to be downloaded by subscribers.

Abstract:

Angiotensin II (AII) is recognized as being an important factor in the pathogenesis of hypertension and atherosclerosis. Monocyte binding to affected endothelial cells is one of the earliest features of atherosclerosis. However, the effect of AII on monocyte binding has not been fully studied. Treatment of human aortic endothelial cells (HAEC) and rabbit aortic endothelial cells (RAEC) for 18 hours with AII induced the adhesion of monocytes but not neutrophils to these cells. This induction was reduced by inhibitors of AII receptors (Type I and Type II). Angiotensin II-induced monocyte binding was not associated with induction of E-selectin, vascular cell adhesion molecule-1 (VCAM-1), or intercellular adhesion molecule-1 (ICAM-1). These results suggest that AII can accelerate the rate of atherosclerosis by increasing monocyte binding to the endothelium.

Language: English

Document Type: Research article

Affiliations: 1: Department of Diabetes & Endocrinology, City of Hope Medical Center, Duarte, CA, 91010 2: Department of Pathology, UCLA School of Medicine, Los Angeles, CA

Publication date: 1996-09-01